Navigation Links
Bush Announces Request for $30B, Five-Year Extension of PEPFAR

President Bush on Wednesday called on Congress to double current funding levels for the President's Emergency Plan for AIDS Relief to $30 billion for five years after the program's original mandate expires next year, the New York Times reports. PEPFAR directs an authorized $15 billion over five years for HIV/AIDS and tuberculosis primarily to 15 focus countries and provides funding to the Global Fund To Fight AIDS, Tuberculosis and Malaria.

PEPFAR's original mandate is scheduled to expire in September 2008, and Bush's request would extend the program for an additional five years. Administration officials have said reauthorization of the program at $30 billion would increase the number of people receiving access to antiretroviral drugs through PEPFAR from 1.4 million to 2.5 million. Bush's announcement comes one week before leaders from the Group of Eight industrialized nations are scheduled to meet in Heiligendamm, Germany, for their 2007 summit.

"Once again, the generosity of the American people is one of the great untold stories of our time," Bush said on Wednesday, adding, "Our citizens are offering comfort to millions who suffer and restoring hope to those who feel forsaken". According to Bush, when he first took office, an "HIV diagnosis in Africa's poorest countries was usually a death sentence," adding that PEPFAR funding has "yielded the best possible return: saved lives."

Many international aid organizations, lawmakers and HIV/AIDS advocates applauded Bush's proposal, the Post reports. "With the energy and resources provided by PEPFAR and other programs, there has been impressive progress in the fight against HIV and AIDS worldwide, but the battle is far from won," Sen. Russell Feingold (D-Wis.), who chairs the Committee on Foreign Relation's Africa subcommittee, said, adding, "Right now, only a small percentage of those who need lifesaving drugs are receiving them, while millions more are contracting this preventa
'"/>




Page: 1 2

Related medicine news :

1. Ramdoss Announces Introduction of RCH-II
2. Britain Announces Third Transfusion Related Mad Cow Case
3. Tibet Announces the Dalai Lama’s Tour of South Americ
4. Indian PM Announces Of Setting Up India Study Center At Tashkent
5. PowderMed Announces Needle-Less Flu Vaccine
6. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
7. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
8. Australian Government Announces Survey To Tackle Childhood Obesity
9. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care
10. Apollo Announces Research on Indian Cardiac Epidemic
11. Government Announces Steps To Promote Ayurvedic Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Bush Announces Request for Five Year Extension PEPFAR

(Date:2/27/2015)... Laguna Hills, CA (PRWEB) February 27, 2015 ... has been chosen as their Sage ERP Document Management ... ERP, Sage 300 ERP, Sage CRM and other complimentary ... ADSS Global have worked side-by-side for many years to ... their Sage ERP applications. , “We are thrilled ...
(Date:2/27/2015)... In New York City, a Brooklyn dentist is ... care from his Sheepshead Bay­neighborhood practice. Dr. Leonard ... Heart, and will be hosting a charity event on ... are in need of fillings, extractions, or professional dental ... high­quality service of Dr. Umanoff's practice on the Dentistry ...
(Date:2/27/2015)... February 27, 2015 The federal court ... that allege use of the statin medication can increase ... issued a new order pertaining discovery in the cases ... Liebhard LLP comments. The Order, which was issued in ... February 25th, directs the parties to schedule certain witness ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 According to ... General Hospital on June 25, 2013 and underwent a ... stomach through her mouth. Because the duodenoscope allegedly ... with the antibiotic-resistant “superbug” carbapenem-resistant Enterobacteriaceae (CRE). ... Court of Cook County on behalf of Ms. Pirolli ...
(Date:2/27/2015)... 2015 Adding to its rich ... Benedict Advertising & Marketing has added Sedation Systems ... company’s patented NITROUSEAL® N20 closed mask and breathing ... sedation. , Sedation Systems, http://www.sedationsystems.com is ... new level, though it focuses primarily on pediatric ...
Breaking Medicine News(10 mins):Health News:Altec Announces 2014 Sage ERP Document Management Partner of the Year Award Recipient 2Health News:Dr. Umanoff Unites with Dentistry from the Heart to Provide Community with Charitable Dental Care 2Health News:Dr. Umanoff Unites with Dentistry from the Heart to Provide Community with Charitable Dental Care 3Health News:Federal Lipitor Litigation Issues New Order Pertaining to Discovery in Bellwether Cases, Bernstein Liebhard LLP Comments 2Health News:Federal Lipitor Litigation Issues New Order Pertaining to Discovery in Bellwether Cases, Bernstein Liebhard LLP Comments 3Health News:Lawsuit Alleges Blame on Scope Manufacturer for "Superbug" Outbreak 2Health News:Benedict Advertising & Marketing Signs Sedation Systems 2
... (CCC) have selected Turning The Tide Together as the theme ... be held in Washington, D.C. from 22 27 July ... moment in time, emphasizing that the AIDS epidemic has reached ... in HIV treatment and biomedical prevention, the momentum for a ...
... TUESDAY, Sept. 20 (HealthDay News) -- People affected by ... without it to develop schizophrenia, and those with schizophrenia ... than people who are not schizophrenic, a new study ... between the two conditions may be due to genetic, ...
... Mitchell, IGB faculty member in the Mining Microbial Genomes ... the Department of Chemistry, is a recipient of the ... The award recognizes bold ideas from some of the ... award, given over a period of five years, supports ...
... about cancer and cancer treatments can feel like learning a ... to understand their treatment options, and the risks and benefits ... death decisions that may affect their survival and they need ... tests can be serious. Patients need to know what kind ...
... An analysis of more than 30,000 cancer patients has ... doctors may realize, causing additional hospitalizations and driving up the ... Duke Cancer Institute researcher. The study, which will be ... in Stockholm, found that as many as one in five ...
... method of family planning developed by researchers from the ... effectively meets the needs of users that they continue to ... that women who follow the Standard Days Method, are likely ... Results of the large, multi-country study of 1659 women appear ...
Cached Medicine News:Health News:Turning the Tide Together: AIDS 2012 theme selected 2Health News:Researchers Find Link Between Epilepsy, Schizophrenia Risk 2Health News:10 ways to make better decisions about cancer care 2Health News:10 ways to make better decisions about cancer care 3Health News:Costly blood clots more common than expected among cancer patients 2Health News:Long-term effectiveness of new family planning method shown in study 2
(Date:2/27/2015)... and HOUSTON, TX , ... the "Company") (TSX-V: EPI) and Bloom Burton & Co. ... from voluntary contractual lock-up (the "Lock-Up") 2,353,130 common shares ... Common Shares originally subject to the Lock-Up. Of the ... be free trading immediately upon release from the Lock-Up ...
(Date:2/27/2015)... -- Boston Scientific Corporation (NYSE: BSX ) is ... Conference on March 10 in Miami Beach ... vice president and chief financial officer, and Susie ... a 25-minute question and answer session regarding the company ... Following a 5-minute break, a question and answer session ...
(Date:2/27/2015)... Feb. 27, 2015   Synageva BioPharma Corp. ... company developing therapeutic products for rare diseases, joins ... European Organisation for Rare Diseases™ (EURORDIS™), The Global ... observing Rare Disease Day. On the ... industry, and other participants conduct special events to ...
Breaking Medicine Technology:ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 3ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 4Boston Scientific to Participate in the Barclays 2015 Annual Healthcare Conference 2Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 2Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 3Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 4Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 5Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 6
... as Marker of,Treatment Success -, SAN FRANCISCO, ... presented at the 59th Annual Meeting of,the American ... shows that,PEGASYS(R) (peginterferon alfa-2a) treatment regimens result in ... patients as,compared to regimens with another pegylated interferon.(1), ...
... Denmark, October 31 , - DoctorConsult in ... Improve Clinician Decision Making and Health Care Business,Performance, ... and more than a,century of experience as a ... provide interactive clinical reference and clinical decision,support (CDS) ...
Cached Medicine Technology:New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients 2New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients 3New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients 4New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients 5New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients 6New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients 7Elsevier is Expanding eClinical Solutions in Europe 2Elsevier is Expanding eClinical Solutions in Europe 3
1.7/2.2 mm Delta System resorbable implant technology merges science and simplicity for a superior craniomaxillofacial surgery product. The system consists of resorbable bone plates and screws fabric...
... A-scan Sonomed-315 is intended for visualization of ... of midline shifts in the brain, evaluation ... easy to use, the Sonomed-315 offers quick ... mode allows to identify the anatomic structures ...
... a scaleable device that works ... platelet plasma or buffy coat. ... coat must be prepared independently ... Starting volume and concentration factor ...
The Ultrafoam Collagen Sponge is indicated in all surgical procedures as an adjunct to hemostasis when control by ligature or conventional procedures are ineffective or impractical....
Medicine Products: